Download Claxton-Hepburn Medical Center

Claxton-Hepburn Medical Center
Richard E. Winter Cancer Treatment Center
2009 Annual Report
Accredited by the American College of Surgeons, Commission on Cancer
Cancer Committee Members 2008
Alka Srivastava, M.D.
Chair person
Medical Oncology
Christopher Brandy, M.D.
Liaison Physician
Surgery
Lucille Alston, M.D.
Medical Oncology
Kay Zimmer, M.S.W.
Oncology Social Worker
Max Laguerre, M.D.
Radiation Oncology
Vicki Perrine, BSN, MHA, FACHE
Vice President, Clinical Services
Eric Li, M.D.
Pathology
Leah Neely, RN, BSN
Performance Improvement
Ali Gharagozloo, M.D.
Radiology
Sanjiv Kashyap
Director, Cancer Center
Juan Diego-Harris, M.D.
Pain Management
Jeanne Raven, RN, OCN
Oncology Nurse
Adam Jarrett, M.D.
Chief Medical Officer
Carol Lytle, RN, CTR
Cancer Registrar
Michele Pelusi
Community Outreach Coordinator
Greg Guimond, RPh
Pharmacy
Alka Srivastava, M.D. - Cancer Committee Chairman
Multidisciplinary care continues to be the focus of our efforts here at Claxton Hepburn
medical Center and the Richard E. Winter Cancer Treatment Center. This ensures that
the knowledge and experience of surgeons, medical oncologists, radiation oncologists
and nurses combine to customize cancer care for each patient. Our goal is to bring to
this community the latest innovations in cancer care. Our accreditation with the
American College of Surgeons and The American College of Radiology recognizes our
dedication to the delivery of comprehensive cancer care.
Vicki Perrine, BSN, MHA, FACHE - Vice President, Clinical Services
In 2008, Claxton Hepburn Medical Center and the Richard E. Winter Cancer Treatment
Center were awarded a three-year accreditation with the American College of Radiology
(ACR). This accreditation, along with our current accreditation from the American
College of Surgeon’s (ACOS), makes our Cancer Treatment Center the only dually
accredited cancer center in the North Country. Obtaining and maintaining the ACR and
ACOS accreditations provides recognition for the high level of quality care that the
Cancer Center staff provides. To add to the quality of services offered at ClaxtonHepburn Medical Center and the Richard E. Winter Cancer Treatment Center, a formal
relationship has been formed with the American Cancer Society (ACS) through the
Cancer Committee. This relationship with ACS will provide additional resources to
patients and family members who have had a cancer diagnosis, to further enhance the
quality of cancer care within our organization.
Adam Jarrett, M.D. - Chief Medical Officer
At Claxton-Hepburn Medical Center and the Richard E. Winter Cancer Treatment Center
we are proud of our accreditation by The American College of Surgeons, Commission on
Cancer and The American College of Radiology. This accreditation certifies that our
patients in the North Country receive the highest quality cancer care, right in their
backyard, with a comprehensive team approach, that incorporates state of the art
technology. What does this mean? Simply put -- on a daily basis our patients receive the
highest quality most compassionate care possible.
Analysis of Cancer Cases at Claxton-Hepburn Medical Center for 2008
In 2008, Claxton-Hepburn Medical Center had a total of 425 reportable oncology
conditions. Of those cases, 357 were analytic. Our total analytic case load was highest in
breast at 18%, lung at 17%, and Colon at 14%.
2008 Analytic Cancer Sites for Claxton-Hepburn Medical Center
BREAST
Top 10 Analytic Sites
LUNG/BRONCHUS-NON SM
CELL
5%
COLON
5%
18%
NON-HODGKIN'S
LYMPHOMA
6%
PROSTATE
8%
MELANOMA OF SKIN
17%
9%
UNKNOWN OR ILL-DEFINED
RECTUM & RECTOSIGMOID
9%
BLADDER
9%
14%
LUNG/BRONCHUS-SMALL
CELL
Analytic Cases: A case first diagnosed and/or treated at Claxton-Hepburn
Medical Center.
Non-Analytic Case: Any case first diagnosed at another facility and received
all of their first course of treatment at that facility, then seen at
Claxton-Hepburn Medical Center for subsequent treatment.
2008 Primary Site Table
Sorted from Most to Least Common Analytic Cases
Site
Total
Group
Cases
ALL SITES
425
BREAST
56
LUNG/BRONCHUS-NON SM CELL
51
COLON
48
NON-HODGKIN'S LYMPHOMA
25
PROSTATE
36
MELANOMA OF SKIN
23
UNKNOWN OR ILL-DEFINED
21
RECTUM & RECTOSIGMOID
21
BLADDER
22
LUNG/BRONCHUS-SMALL CELL
15
OTHER HEMATOPOIETIC
8
MYELOMA
7
ESOPHAGUS
6
LEUKEMIA
7
OVARY
7
PANCREAS
5
KIDNEY AND RENAL PELVIS
5
BRAIN
5
CORPUS UTERI
6
LARYNX
4
SOFT TISSUE
3
VULVA
3
MOUTH, OTHER & NOS
3
PERITONEUM,OMENTUM,MESENT
3
OTHER ENDOCRINE
3
HODGKIN'S DISEASE
3
TONGUE
2
TONSIL
2
STOMACH
2
OTHER SKIN CA
2
OTHER FEMALE GENITAL
2
THYROID
2
RETROPERITONEUM
2
PLEURA
2
CERVIX UTERI
2
LIP
1
SALIVARY GLANDS, MAJOR
1
SMALL INTESTINE
1
LIVER
1
GALLBLADDER
1
BONE
1
KAPOSIS SARCOMA
1
TESTIS
1
PENIS
1
OTHER NERVOUS SYSTEM
1
ANUS,ANAL CANAL,ANORECTUM
1
Analytic
357
50
44
38
24
23
23
20
16
14
14
7
6
6
5
5
5
5
5
4
4
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
0
Class
Non-Analytic
68
6
7
10
1
13
0
1
5
8
1
1
1
0
2
2
0
0
0
2
0
0
0
1
1
1
1
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
1
Sex
M
200
0
24
27
13
36
13
6
12
14
8
5
4
6
5
0
1
2
3
0
2
1
0
1
0
1
2
1
2
2
2
0
0
0
2
0
0
1
0
0
0
1
1
1
1
0
0
F
225
56
27
21
12
0
10
15
9
8
7
3
3
0
2
7
4
3
2
6
2
2
3
2
3
2
1
1
0
0
0
2
2
2
0
2
1
0
1
1
1
0
0
0
0
1
1
2008 Colon Cancer Analytic Data for
Claxton-Hepburn Medical Center
Claxton-Hepburn Medical Center’s
Analytic Colon Cases
2004-2008
2004
2005
2006
2007
2008
50
46
39
39
38
Each year Cancer committee publishes a report focusing on a specific type of
cancer. This report provides clinical data on incidence of cancer and survival rates and
analyzes them against data from other hospitals in New York State and the nation. The
most recent report focuses on colon cancer.
The following tables compare age at diagnosis of colon cancer cases at Claxton
Hepburn Medical Center and the Richard E. Winter Cancer Treatment Center to that of
colon cancer cases in the state of New York and cancer centers across the country. The
data shows that the ages of patients seen here at our organization is quite similar.
2004-2008 Claxton-Hepburn Medical Center
Age at Diagnosis
Analytic Colon Cases
90-99
1.89%
17.45%
Age Range
70-79
23.11%
29.25%
50-59
20.28%
6.60%
30-39
0.94%
0.47%
0-15
0%
0%
5%
10%
15%
20%
Percentage
25%
30%
35%
Age at Diagnosis for NCDB 2000-2006 Cases
Community Hospital Cancer Programs:
State of New York - Data from 19 Hospitals
Age at Diagnosis
90-99
4.25%
26.49%
70-79
29.82%
21.09%
50-59
12.56%
4.64%
30-39
0.97%
0.16%
0-15
0.02%
0%
5%
10%
15%
20%
25%
30%
35%
Percentage
Source: NCDB, Commission on Cancer, ACoS, Benchmark Reports v9.0
Age at Diagnosis for NCDB 2000-2006 Cases
Community Cancer Programs:All States
Data from 473 Hospitals
Age at Diagnosis
90-99
1.33%
12.19%
70-79
21.18%
22.36%
50-59
23.08%
15.93%
30-39
3.64%
0.30%
0-15
0%
0%
5%
10%
15%
Percentage
Source: NCDB, Commission on Cancer, ACoS, Benchmark Reports v9.0
20%
25%
5 Year Survival Rates for Colon Cancer
Cancer survival rates tell you the percentage of people who survive a certain type
of cancer for a specific amount of time. Cancer statistics often use a five-year survival
rate.
In this table the cancer survival rate of colon cancer patients (any stage) are
compared to the survival rates from data submitted to the commission on cancer from
local and national cancer centers. Again our data looks very comparable to the centers
nation wide.
Actuarial Method
Colon Cancer 5 Year Observed Survival Rates
100
Cumulative Survival Rate
90
80
70
Claxton-Hepburn Medical Center
60
50
Cancer Programs for NY, NJ, PA
(188 Cancer Programs)
40
30
National Cancer Programs
(481 Cancer Programs)
20
10
0
0
1
2
3
Years
4
5